Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-15

Clinical Trial Update: OMEGA-3-FATTY ACIDS IN CHILDREN WITH SICKLE CELL DISEASE [NA]

View source ↗

Summary

A clinical trial update shows a study evaluating omega-3 fatty acids in children with sickle cell disease. The study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Sickle Cell Disease (SCD) | NA | Status: NOT_YET_RECRUITING